Coghlan first explains how the study was conducted. He says that a group of 630 people was split up equally into three categories: one-third was given delta-9-tetrahydrocannabinol (THC), one-third was given a marijuana extract, and one-third was given a placebo. He informs readers that the study was mainly performed to establish the effects of marijuana on spasticity associated with Multiple Sclerosis (p.13).
The author goes on to elaborate on the reason why his article reflects only a limited victory for marijuanas medicinal legislation. He states that even though more patients that actually received active marijuana ingredients in their pills claimed relief from their symptoms, there was still a fairly high percentage that claimed relief from the placebo (p.13).
He concludes with a statement made by Alan Thompson, from the National Hospital for Neurology and Neurosurgery in London: The major problem with smoking is making sure you know how much active component is in the blood, and the second problem is the cancer risk. This is why, Coghlan says, that scientists advise against the actual smoking of marijuana, but rather the use of drugs made from the active ingredients inside it (p.13).
Conversely, Mike A. Males (2005, pp.31-33) talks about one particular aspect that current drug policies are based on. He discusses the use and misuse of surveys given to high school students and young adults by two government sponsored organizations: Monitoring the Future (MTF) and Parents Resource Institute for Drug Education (PRIDE).
He explains that anti-drug campaigns for our children are often based on the results from these two surveys. He says that if the outcome of these surveys shows an increase in drug use, that it could put an end the current drug education program, on the other hand if there is a decrease, then accomplishment of the program is acknowledged (p.31).
The author goes on to explain that further ana View More »